PF169 LONG‐TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTS
Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Giovanni Martinelli(University of Bologna), Matteo Bocconcelli(University of Bologna), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Antonella Padella(University of Bologna), Carmen Baldazzi(University of Bologna), Anna Ferrari(University of Bologna), Enrica Imbrogno(University of Bologna), Maria Chiara Fontana(Istituto Oncologico Romagnolo)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644